Cover Image
市場調查報告書

全球血漿市場

Global Blood Plasma Market Report: 2016 Edition

出版商 Koncept Analytics 商品編碼 233439
出版日期 內容資訊 英文 57 Pages
訂單完成後即時交付
價格
Back to Top
全球血漿市場 Global Blood Plasma Market Report: 2016 Edition
出版日期: 2016年06月27日 內容資訊: 英文 57 Pages
簡介

本報告提供全球血漿市場相關調查分析,以主要地區市場為焦點,提供主要趨勢和發展,課題,競爭情形,主要企業簡介等系統性資訊。

第1章 概要

  • 血漿的成分
  • 血漿的功能
  • 血漿的收集、開採

第2章 全球市場分析

  • 全球血漿市場
  • 全球免疫球蛋白 (Ig) 市場
  • 全球白蛋白市場
  • 全球血漿來源第八凝血因子市場
  • 全球A1PI市場

第3章 美國的血漿市場

  • 美國的血漿分餾能力
  • 美國的血液製劑的利用:各類別
  • 美國的免疫球蛋白 (Ig) 市場

第4章 中國的血漿市場

  • 中國的血漿市場收益
  • 中國的血漿的收集數量
  • 中國的血漿的生產量
  • 中國的人體血清蛋白市場收益
  • 中國的免疫球蛋白 (Ig) 市場收益

第5章 市場動態

  • 成長推動因素
  • 主要趨勢
  • 課題

第6章 競爭情形

  • 競爭:各市場佔有率
  • 競爭:各市值

第7章 企業簡介

  • Grifols
  • Baxter International Inc
  • CSL Limited
  • Octapharma AG

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The raw material for blood plasma industry is the liquid that is a component of blood called blood plasma. Blood plasma makes up approximately 55% of the total blood volume. Blood plasma is pale yellow in color and consists of water, proteins and salt. Those proteins are used to produce medicinal products for treatment of a variety of life-threatening diseases, illnesses and conditions. These plasma-derived medications are the standard course of treatment for thousands of people, in more than 100 countries across the globe, who need the treatment to improve their health and lead productive lives.

The chief components of the global blood plasma market are immunoglobulin, albumin, factor VIII and Alpha-1 proteinase inhibitor (A1PI) or alpha-1 antitrypsin (AAT). These components are proteins and antibodies that are extracted from the fractionated blood plasma and used for the treatment of various indications.

The key factors which are anticipated to drive this market include rising healthcare expenditure, growing demand for polyvalent immunoglobulin and increasing market for albumin in the Asia-pacific. Some of the noteworthy progresses of this industry include the new potential for raising AATD diagnosis and introduction of extended half-life products for hemophilia. However, the growth of respective industry is challenged by the high cost of production that discourages new entrants, shrinking market for plasma-derived factor VIII, high industry regulation in the emerging market and increasing threat of substitutes.

The report provides a wide-ranging study of global blood plasma market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are examined in depth. The global blood plasma market is highly competitive consisting of several large conglomerates including Baxter international, CSL, Grifols, Octapharma etc. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.

Table of Contents

1. Overview

  • 1.1 Components of Blood Plasma
    • 1.1.1 Proteins
    • 1.1.2 Amino Acids
    • 1.1.3 Electrolytes
    • 1.1.4 Nutrients
    • 1.1.5 Gases
    • 1.1.6 Nitrogenous Waste
  • 1.2 Functions of Blood Plasma
    • 1.2.1 Carry Nutrients
    • 1.2.2 Maintain Equilibrium of Electrolytes
    • 1.2.3 Sustain Blood Volume
    • 1.2.4 Safeguard the Body
    • 1.2.5 Removal of Waste
  • 1.3 Collection and Extraction of Plasma
    • 1.3.1 Plasma Collection
    • 1.3.2 Plasma Extraction
    • 1.3.3 Plasma Fractionation Yield
    • 1.3.4 Plasma Usage

2. Global Market Analysis

  • 2.1 Global Blood Plasma Market
    • 2.1.1 Global Blood Plasma Market Revenue
    • 2.1.2 Global Blood Plasma Market by Category
    • 2.1.3 Global Blood Derivative Drugs Market by Region - Value
    • 2.1.4 Global Blood Derivative Drugs Market by Patient Count
  • 2.2 Global Immunoglobulin Market
    • 2.2.1 Global Immunoglobulin Market Revenue
    • 2.2.2 Global Intravenous and Subcutaneous Immunoglobulin Demand
  • 2.3 Global Albumin Market
    • 2.3.1 Global Albumin Market Revenue
    • 2.3.2 Global Albumin Market by Volume
  • 2.4 Global Plasma-Derived Factor VIII Market
    • 2.4.1 Global Factor VIII Market Revenue by Category
    • 2.4.2 Global Plasma-Derived Factor VIII Revenue
  • 2.5 Global A1PI Market
    • 2.5.1 Global A1PI Market Revenue
    • 2.5.2 Global AATD Patient Count

3. The US Blood Plasma Market

  • 3.1 The US Plasma Fractionation Capacity
  • 3.2 The US Blood Derivative Usage by Category
  • 3.3 The US Immunoglobulin Market
    • 3.3.1 The US Immunoglobulin Market Revenue
    • 3.3.2 The US Immunoglobulin Market by Volume
    • 3.3.3 The US Immunoglobulin Market Volume by Category
    • 3.3.4 The US Intravenous Immunoglobulin (IVIG) Market by Volume
    • 3.3.5 The US Subcutaneous Immunoglobulin (SCIG) Market by Volume
    • 3.3.6 The US IV/SCIG Market by Medical Specialty

4. China Blood Plasma Market

  • 4.1 China Blood Plasma Market Revenue
  • 4.2 China Blood Plasma Collection Volume
  • 4.3 China Blood Plasma Output Volume
  • 4.4 China Human Albumin Market Revenue
  • 4.5 China Immunoglobulin Market Revenue

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Growing Demand for Polyvalent Immunoglobulin
    • 5.1.2 Increasing Market for Albumin in the Asia-Pacific
    • 5.1.3 Rising Healthcare Expenditure
  • 5.2 Key Trends
    • 5.2.1 New Potential for Raising AATD Diagnosis
    • 5.2.2 Introduction of Extended Half-Life Products for Hemophilia
  • 5.3 Challenges
    • 5.3.1 High Cost of Production Discourages New Entrants
    • 5.3.2 Shrinking Market for Plasma-Derived Factor VIII
    • 5.3.3 High Industry Regulations in Emerging Market - China
    • 5.3.4 Increasing Threat of Substitutes

6. Competitive Landscape

  • 6.1 Competition by Market Share
    • 6.1.1 Global Blood Derivative Drugs Market Share
    • 6.1.2 Global IVIG Market Share
    • 6.1.3 Global AAT Market Share
    • 6.1.4 The US Plasma Protein Market Share
  • 6.2 Competition by Market Capitalization

7. Company Profiles

  • 7.1 Grifols
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Baxter International Inc
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 CSL Limited
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Octapharma AG
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Charts

  • Plasma Extraction from Donated Blood (Recovered Plasma)
  • Plasmapheresis (Sourced Plasma)
  • Global Blood Plasma Market Revenue (2013-2018F)
  • Global Blood Plasma Market by Category (2015)
  • Global Blood Derivative Drugs Market by Region - Value (2015)
  • Global Blood Derivative Drugs Market by Patient Count (2015)
  • Global Immunoglobulin Market Revenue (2013-2018F)
  • Global Intravenous and Subcutaneous Immunoglobulin Demand (2010-2015E)
  • Global Albumin Market Revenue (2013-2018F)
  • Global Albumin Market by Volume (2010-2020F)
  • Global Factor VIII Market Revenue by Category (2015)
  • Global Plasma-Derived Factor VIII Revenue (2013-2018F)
  • Global A1PI Market Revenue (2013-2018F)
  • Global AATD Patient Count (2014-2020)
  • The US Plasma Fractionation Capacity - Actuals (2012-2015E)
  • The US Plasma Fractionation Capacity - Forecast (2016F-2020F)
  • The US Blood Derivative Usage by Category (2015)
  • The US Immunoglobulin Market Revenue (2013-2018F)
  • The US Immunoglobulin Market by Volume (2013-2020F)
  • The US Immunoglobulin Market Volume by Category (2015)
  • The US Intravenous Immunoglobulin (IVIG) Market by Volume (2013-2020F)
  • The US Subcutaneous Immunoglobulin (SCIG) Market by Volume (2013-2020F)
  • The US IV/SCIG Market by Medical Specialty (2016F)
  • China Blood Plasma Market Revenue (2014-2020F)
  • China Blood Plasma Collection Volume (2008-2015E)
  • China Blood Plasma Output Volume (2012-2015E)
  • China Human Albumin Market Revenue (2013-2020F)
  • China Immunoglobulin Market Revenue (2014-2020F)
  • Global Demand for Polyvalent Immunoglobulin (2008-2020F)
  • Asia-Pacific Albumin Market by Volume (2010-2020F)
  • Global Healthcare Expenditure (2010-2015E)
  • Global Blood Derivative Drugs Market Share (2015)
  • Global IVIG Market Share (2015)
  • Global AAT Market Share (2015)
  • The US Plasma Protein Market Share (2015)
  • Market Cap Comparison of Key Players (2015)
  • Revenue Share by Business Segments, Grifols (2015)
  • Revenue and Net Income, Grifols (2011-2015)
  • Revenue Share by Business Segments, Baxter International Inc (2015)
  • Revenue and Net Income, Baxter International Inc (2013-2015)
  • Revenue Share by Business Segments (2015)
  • Revenue and Net Income, CSL Limited (2011-2015)
  • Revenue and Net Income, Octapharma AG (2011-2015)

List of Tables

  • Clinical Uses of Plasma Proteins
  • Recovered Plasma vs. Sourced Plasma
  • Output per Liter of Plasma
  • Extended Half-Life Products under Development (2015)
Back to Top